Cargando…
RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
Recombinant T cell receptor ligands (RTLs) that target encephalitogenic T-cells can reverse clinical and histological signs of EAE, and are currently in clinical trials for treatment of multiple sclerosis. To evaluate possible regulatory mechanisms, we tested effects of RTL therapy on expression of...
Autores principales: | Sinha, Sushmita, Miller, Lisa M., Subramanian, Sandhya, Burrows, Gregory G., Vandenbark, Arthur A., Offner, Halina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130056/ https://www.ncbi.nlm.nih.gov/pubmed/21750737 http://dx.doi.org/10.1371/journal.pone.0021868 |
Ejemplares similares
-
Role of BET Proteins in Inflammation and CNS Diseases
por: Liu, Lei, et al.
Publicado: (2021) -
CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model
por: Wang, Ning, et al.
Publicado: (2020) -
Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model
por: Zerimech, Sarah, et al.
Publicado: (2023) -
To Bet or Not to Bet on T-bet As a Therapeutic Target in Emphysema?
por: Wang, Xiaoyun, et al.
Publicado: (2019) -
Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE
por: Seifert, Hilary A., et al.
Publicado: (2019)